HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-(p-methoxyphenyl)adenosine

structure

Also Known As:

CV 1674; CV-1674; 2-(4-methoxyphenyl)adenosine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Adenosine: 12431
        2-(p-methoxyphenyl)adenosine: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Adenosine: 12431
      - 2-(p-methoxyphenyl)adenosine: 1
  - Ribonucleosides: 49
    - Adenosine: 12431
      - 2-(p-methoxyphenyl)adenosine: 1

Related Diseases

1.	Hypotension (Low Blood Pressure) 10/01/1977 - " CV-1674 (250 and 500 microgram/kg) increased myocardial tissue blood flow (MBF) with a slight hypotension in a dose-dependent manner, whereas 2-Cl-ADS (100, 250 and 500 microgram/kg) increased MBF only with the highest dose concomitantly with marked hypotension and bradycardia. "
2.	Bradycardia 10/01/1977 - "ADS produced a marked bradycardia that was not evident with CV-1674. " 10/01/1977 - " CV-1674 (250 and 500 microgram/kg) increased myocardial tissue blood flow (MBF) with a slight hypotension in a dose-dependent manner, whereas 2-Cl-ADS (100, 250 and 500 microgram/kg) increased MBF only with the highest dose concomitantly with marked hypotension and bradycardia. "